Mr. Richard Reyes 3.pdf

More documents

Recommendations

Info

10 years on:1. Size of IMC metastasis2. Staging N1v N3 – if IMC alone N1, if combined N3?3. Role for surgery – IMC and other SNLB, ?Lacour and Meiersubset analysis4. If not assessing routinely with SLNB, indications and protocols forDXT – is there only local benefit?• Primary tumour medial and above a certain size?• Axillary involvement5. IMC +ve SN – protocols need to be standardised but how doesone trial this?6. How to manage the Non axillary SN with axilla –ve for SN?• Traditionally by clearance but SLNB with dye revealed SNsin 8/23, 10/15 ANC avoided and these patients still DF.
Axillary Lymphatic Mapping AgainstNodal Axillary Clearance(ALMANAC)Trial – 2006 (New Start)
Page 1 and 2: Mr. Richard J. ReyesMBBS, MS, FRCS(
Page 3 and 4: What is it and Why?Improve our unde
Page 5 and 6: Why sentinel lymph-node biopsy wasi
Page 7 and 8: Impact of non-axillary sentinel nod
Page 9 and 10: Pathologic classification (pN):pN1:
Page 11 and 12: Overall SurvivalIsolated IMC metast
Page 13 and 14: Lacour 1983, Meier 1989Extended rad
Page 15 and 16: pN1pN1Micrometastases.ORMetastases
Page 17 and 18: pN3Metastases in ≥10 axillary lym
Page 19: The Manchester System For the Stagi
Page 23: Thank you

Mr. Richard Reyes 3.pdf

Create successful ePaper yourself

Delete template?

Save as template?